Daniel Chernavvsky

Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe

Claudio Cobelli, Giordano Lanzola, Lalo Magni, 2016, Diabetes Care.

Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp

Marc D. Breton, Boris P. Kovatchev, Bruce A. Buckingham, 2014, Diabetes Care.

Multinational Home Use of Closed-Loop Control Is Safe and Effective

Marc D. Breton, Eyal Dassau, Francis J. Doyle, 2016, Diabetes Care.

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Eyal Dassau, Claudio Cobelli, Marc D Breton, 2017, Diabetes technology & therapeutics.

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.

Stephen D Patek, Marc D Breton, Chiara Fabris, 2018, Diabetes technology & therapeutics.

Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.

Lieve Moons, Florea Lupu, Peter Carmeliet, 2002, Journal of the American Society of Nephrology : JASN.

Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting

Claudio Cobelli, Giordano Lanzola, Lalo Magni, 2016, Diabetes Care.